VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 58 filers reported holding VERRICA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35 | -63.2% | 9,123 | -44.4% | 0.00% | – |
| Q2 2023 | $95 | – | 16,400 | +12712.5% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 128 | -98.4% | 0.00% | – |
| Q1 2022 | $67,000 | -10.7% | 8,235 | 0.0% | 0.00% | – |
| Q4 2021 | $75,000 | -27.2% | 8,235 | 0.0% | 0.00% | – |
| Q3 2021 | $103,000 | +10.8% | 8,235 | +0.2% | 0.00% | – |
| Q2 2021 | $93,000 | -24.4% | 8,218 | +1.4% | 0.00% | – |
| Q1 2021 | $123,000 | +127.8% | 8,107 | +72.5% | 0.00% | – |
| Q4 2020 | $54,000 | +50.0% | 4,700 | 0.0% | 0.00% | – |
| Q3 2020 | $36,000 | -76.3% | 4,700 | -65.9% | 0.00% | – |
| Q2 2020 | $152,000 | +0.7% | 13,800 | 0.0% | 0.00% | – |
| Q1 2020 | $151,000 | -31.1% | 13,800 | 0.0% | 0.00% | – |
| Q4 2019 | $219,000 | +7.4% | 13,800 | 0.0% | 0.00% | – |
| Q3 2019 | $204,000 | +27.5% | 13,800 | 0.0% | 0.00% | – |
| Q2 2019 | $160,000 | +332.4% | 13,800 | +305.9% | 0.00% | – |
| Q1 2019 | $37,000 | +32.1% | 3,400 | 0.0% | 0.00% | – |
| Q4 2018 | $28,000 | – | 3,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,038,983 | $9,675,000 | 0.30% |
| Fosun International Ltd | 282,408 | $543,000 | 0.08% |
| CVI Holdings, LLC | 450,000 | $864,000 | 0.06% |
| Ground Swell Capital, LLC | 10,205 | $20,000 | 0.04% |
| XTX Topco Ltd | 25,795 | $50,000 | 0.02% |
| SteelPeak Wealth, LLC | 134,661 | $259,000 | 0.02% |
| Miracle Mile Advisors, LLC | 125,000 | $240,000 | 0.01% |
| Point72 Asset Management, L.P. | 753,945 | $1,448,000 | 0.01% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 38,687 | $74,000 | 0.01% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 129,251 | $248,000 | 0.01% |